Skip to main content

Hojoon Sohn

Seoul National University · 医学

研究室紹介

Professor Hojoon Sohn's research lab specializes in health systems and implementation science, with a focus on improving tuberculosis (TB) control through innovative diagnostics, cost-effective implementation strategies, and health policy evaluation. The lab investigates the real-world performance, cost, and cost-effectiveness of molecular diagnostic tools—particularly Xpert MTB/RIF—across diverse health systems, especially in low- and middle-income countries. A central theme is bridging the gap between research evidence and public health decision-making by rigorously assessing implementation costs and operational impacts on diagnostic and treatment delays. The lab also explores scalable, integrated approaches to active case finding and decentralized testing to enhance case detection and health system efficiency.

tuberculosisdiagnostic implementationcost-effectivenessXpert MTB/RIFhealth systems research

Research Overview

Papers
104
Total Citations
2,529
Papers (5y)
59
Primary Field
医学

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
59total
2022
2023
2024
2025
2026
Citations per year (5y)
315total
20222023202420252026

Selected Papers

15
1
letter|123 citations·2020
Costing the implementation of public health interventions in resource-limited settings: a conceptual framework
Hojoon Sohn, Austin Tucker, Olivia Ferguson, Isabella Gomes, David W. Dowdy
SJR Q1Implementation ScienceOA

BACKGROUND: Failing to account for the resources required to successfully implement public health interventions can lead to an underestimation of costs and budget impact, optimistic cost-effectiveness estimates, and ultimately a disconnect between published evidence and public health decision-making. METHODS: We developed a conceptual framework for assessing implementation costs. We illustrate the use of this framework with case studies involving interventions for tuberculosis and HIV/AIDS in re

General Health ProfessionsHealth Professions
2
Article|99 citations·2014
Xpert MTB/RIF Testing in a Low Tuberculosis Incidence, High-Resource Setting: Limitations in Accuracy and Clinical Impact
Hojoon Sohn, Abebech D. Aero, Dick Menzies, Marcel A. Behr, Kevin Schwartzman, Gonzalo G. Alvarez, Andrei Dan, Fiona McIntosh, Madhukar Pai, Claudia M. Denkinger
SJR Q1Clinical Infectious DiseasesOA

BACKGROUND: Xpert MTB/RIF, the first automated molecular test for tuberculosis, is transforming the diagnostic landscape in low-income countries. However, little information is available on its performance in low-incidence, high-resource countries. METHODS: We evaluated the accuracy of Xpert in a university hospital tuberculosis clinic in Montreal, Canada, for the detection of pulmonary tuberculosis on induced sputum samples, using mycobacterial cultures as the reference standard. We also assess

Infectious DiseasesMedicine
3
Review|36 citations·2009
TB diagnostic tests: how do we figure out their costs?
Hojoon Sohn, Jessica Minion, Heidi Albert, Keertan Dheda, Madhukar Pai
SJR Q1Expert Review of Anti-infective TherapyOA

Tuberculosis continues to be a major global health problem. Lack of accurate, rapid and cost-effective diagnostic tests poses a huge obstacle to global TB control. While several new diagnostic tools are being developed and evaluated for TB, it is important that new tools are introduced for widespread use only after careful validation of accuracy, impact as well as cost-effectiveness in real-world settings. While there are large numbers of studies on the accuracy of TB diagnostic tests, there are

Infectious DiseasesMedicine
4
Review|35 citations·2022
Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis
Jae Hyoung Lee, Tushar Garg, Jungsil Lee, Sean McGrath, Lori Rosman, Samuel G. Schumacher, Andrea Benedetti, Zhi Zhen Qin, Geneviève Gore, Madhukar Pai, Hojoon Sohn
SJR Q1BMC Infectious DiseasesOA

BACKGROUND: Countries with high TB burden have expanded access to molecular diagnostic tests. However, their impact on reducing delays in TB diagnosis and treatment has not been assessed. Our primary aim was to summarize the quantitative evidence on the impact of nucleic acid amplification tests (NAAT) on diagnostic and treatment delays compared to that of the standard of care for drug-sensitive and drug-resistant tuberculosis (DS-TB and DR-TB). METHODS: We searched MEDLINE, EMBASE, Web of Scien

Infectious DiseasesMedicine
5
Article|30 citations·2021
Costs and cost-effectiveness of a comprehensive tuberculosis case finding strategy in Zambia
Youngji Jo, Mary Kagujje, Karl Johnson, David W. Dowdy, Peter Hangoma, Lophina Chiliukutu, Monde Muyoyeta, Hojoon Sohn
SJR Q1PLoS ONEOA

INTRODUCTION: Active-case finding (ACF) programs have an important role in addressing case detection gaps and halting tuberculosis (TB) transmission. Evidence is limited on the cost-effectiveness of ACF interventions, particularly on how their value is impacted by different operational, epidemiological and patient care-seeking patterns. METHODS: We evaluated the costs and cost-effectiveness of a combined facility and community-based ACF intervention in Zambia that utilized mobile chest X-ray wit

Infectious DiseasesMedicine
6
Article|26 citations·2019
Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model
Hojoon Sohn, Parastu Kasaie, Emily A. Kendall, Gabriela B. Gomez, Anna Vassall, Madhukar Pai, David W. Dowdy
SJR Q1BMC MedicineOA

BACKGROUND: India and many other high-burden countries have committed to providing universal access to high-quality diagnosis and drug susceptibility testing (DST) for tuberculosis (TB), but the most cost-effective approach to achieve this goal remains uncertain. Centralized testing at district-level hub facilities with a supporting sample transport network can generate economies of scale, but decentralization to the peripheral level may provide faster diagnosis and reduce losses to follow-up (L

Infectious DiseasesMedicine
7
Article|25 citations·2022
Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda
Ryan Thompson, Alex Kityamuwesi, Alice Kuan, Denis Oyuku, Austin Tucker, Olivia Ferguson, Lynn Kunihira Tinka, Rebecca Crowder, Stavia Turyahabwe, Adithya Cattamanchi, David W. Dowdy, Achilles Katamba
SJR Q1Value in HealthOA
General Health ProfessionsHealth Professions
8
Article|25 citations·2023
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
Ryan Thompson, Talemwa Nalugwa, Denis Oyuku, Austin Tucker, Mariam Nantale, Annet Nakaweesa, Johnson Musinguzi, Tania Reza, A. Zimmer, Olivia Ferguson, Stavia Turyahabwe, Moses Joloba
SJR Q1The Lancet Global HealthOA

BACKGROUND: Decentralised molecular testing for tuberculosis could reduce missed diagnoses and losses to follow-up in high-burden settings. The aim of this study was to evaluate the cost and cost-effectiveness of the Xpert Performance Evaluation for Linkage to Tuberculosis Care (XPEL-TB) study strategy, a multicomponent strategy including decentralised molecular testing for tuberculosis, in Uganda. METHODS: We conducted a costing and cost-effectiveness analysis nested in a pragmatic cluster-rand

Infectious DiseasesMedicine
9
Article|22 citations·2021
Determining the value of TB active case-finding: current evidence and methodological considerations
Hojoon Sohn, Sedona Sweeney, Don Mudzengi, J. Creswell, Nicholas Menzies, Gregory J. Fox, Peter MacPherson, David W. Dowdy
SJR Q1The International Journal of Tuberculosis and Lung DiseaseOA

Active case-finding (ACF) is an important component of the End TB Strategy. However, ACF is resource-intensive, and the economics of ACF are not well-understood. Data on the costs of ACF are limited, with little consistency in the units and methods used to estimate and report costs. Mathematical models to forecast the long-term effects of ACF require empirical measurements of the yield, timing and costs of case detection. Pragmatic trials offer an opportunity to assess the cost-effectiveness of

Economics and EconometricsEconomics, Econometrics and Finance
10
reference-entry|21 citations·2012
Xpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance
Hojoon Sohn, Madhukar Pai, Nandini Dendukuri, Lorie A. Kloda, Catharina Boehme, Karen R Steingart
SJR Q1Cochrane Database of Systematic Reviews

This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: Primary objectives Review question A: To obtain summary estimates of the diagnostic accuracy of Xpert MTB/RIF for the diagnosis of pulmonary TB, using solid or liquid culture as a reference standard. Purpose of index test: A.1 Xpert MTB/RIF as a replacement test for smear microscopy. A.2. Xpert MTB/RIF as an add‐on test after smear microscopy. Review question B: To obtain summary estimates of the

Infectious DiseasesMedicine
11
Article|18 citations·2020
Standardized framework for evaluating costs of active case-finding programs: An analysis of two programs in Cambodia and Tajikistan
Youngji Jo, Ф. М. Мирзоева, Monyrath Chry, Zhi Zhen Qin, Andrew James Codlin, Oktam Bobokhojaev, Jacob Creswell, Hojoon Sohn
SJR Q1PLoS ONEOA

Results from two contextually and programmatically different multi-component ACF programs demonstrate that our tool is fully capable of comprehensively and transparently evaluating and comparing costs of various ACF programs.

Infectious DiseasesMedicine
12
Article|13 citations·2019
Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
Sanjay Sarin, Sophie Huddart, Neeraj Raizada, Debadutta Parija, Aakshi Kalra, Raghuram Rao, Virender Singh Salhotra, Sunil Khaparde, Catharina Boehme, Claudia M. Denkinger, Hojoon Sohn
SJR Q1PLoS ONEOA

Xpert test and outreach program costs within and across study sites were mainly driven by the dynamics of Xpert testing demand resulting from the combined outreach activities. However, these increases in demand required considerable overtime work resulting in additional costs and operational challenges at the study laboratories. Therefore, careful laboratory operational adjustment should be evaluated at target areas in parallel to the anticipated demand from the Xpert referral outreach program s

Infectious DiseasesMedicine
13
Article|13 citations·2009
Fluorescence microscopy is less expensive than Ziehl-Neelsen microscopy in Thailand.
Hojoon Sohn, Chalinthorn Sinthuwattanawibool, Somsak Rienthong, Jay K. Varma
PubMed

Ziehl-Neelsen (ZN) microscopy is the primary method for acid-fast bacilli examination in resource-limited settings, including Thailand. Despite its considerably improved diagnostic performance, conventional fluorescent microscopy (FM) is rarely used due to its perceived high cost. An evaluation in Thailand found that the total cost of FM operated in the National Tuberculosis Reference Laboratory (NTRL) in Bangkok, Thailand, is similar to that of ZN performed in the NTRL and in four regional Thai

Infectious DiseasesMedicine
14
Article|12 citations·2019
Operational characteristics of antiretroviral therapy clinics in Zambia: a time and motion analysis
Radhika P. Tampi, Taniya Tembo, Mpande Mukumba-Mwenechanya, Anjali Sharma, David W. Dowdy, Charles B. Holmes, Carolyn Bolton‐Moore, Izukanji Sikazwe, Austin Tucker, Hojoon Sohn
SJR Q1BMC Health Services ResearchOA

BACKGROUND: The mass scale-up of antiretroviral therapy (ART) in Zambia has taken place in the context of limited infrastructure and human resources resulting in many operational side-effects. In this study, we aimed to empirically measure current workload of ART clinic staff and patient wait times and service utilization. METHODS: We conducted time and motion (TAM) studies from both the healthcare worker (HCW) and patient perspectives at 10 ART clinics throughout Zambia. Trained personnel recor

Infectious DiseasesMedicine
15
Article|11 citations·2018
Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea
Hojoon Sohn, H-Y. Kim, Sang‐Hoon Lee
SJR Q1The International Journal of Tuberculosis and Lung Disease

The TST-alone strategy was the most cost-effective; the QFT-GIT-alone strategy averted the greatest number of TB cases but incurred the highest cost in contact investigation for school TB outbreaks.

Infectious DiseasesMedicine

Research Areas

Infectious DiseasesEpidemiologyGeneral Health ProfessionsEconomics and EconometricsBiomedical EngineeringMolecular Biology

Hojoon Sohnの研究をNubintでさらに深く

この研究室の論文をアプリで開き、AIと共に読み、要約し、引用しましょう。